Citigroup’s Elanco Animal Health ELAN Stock Holding History

Citigroup’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-45,000	Closed	-$545K	–	5683
2024 Q4	$545K	Hold	45,000	–	–	﹤0.01%	3760
2024 Q3	$661K	Buy	+45,000	New	+$627K	﹤0.01%	3554
2024 Q2	–	Sell	-29,400	Closed	-$479K	–	5625
2024 Q1	$479K	Buy	+29,400	New	+$460K	﹤0.01%	3607
2023 Q4	–	Sell	-30,000	Closed	-$337K	–	5743
2023 Q3	$337K	Hold	30,000	–	–	﹤0.01%	3343
2023 Q2	$302K	Buy	+30,000	New	+$278K	﹤0.01%	3677
2021 Q1	–	Sell	-24,700	Closed	-$758K	–	6547
2020 Q4	$758K	Buy	24,700 +2,800	+13%	+$85.4K	﹤0.01%	3824
2020 Q3	$612K	Buy	21,900 +4,900	+29%	+$124K	﹤0.01%	3687
2020 Q2	$365K	Sell	17,000 -15,600	-48%	-$345K	﹤0.01%	4541
2020 Q1	$730K	Sell	32,600 -12,100	-27%	-$331K	﹤0.01%	3503
2019 Q4	$1.32M	Buy	44,700 +19,200	+75%	+$522K	﹤0.01%	3460
2019 Q3	$678K	Buy	25,500 +12,600	+98%	+$378K	﹤0.01%	4048
2019 Q2	$436K	Buy	+12,900	New	+$419K	﹤0.01%	4549

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Citigroup's ELAN Position: Q1 2026 in Review

Citigroup reduced its Elanco Animal Health (ELAN) stake by 28% in Q1 2026, selling an estimated $2.1M and leaving 220,452 shares worth $5.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

Citigroup first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $50.7M in Q1 2019. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Citigroup held 220,452 shares of Elanco Animal Health worth $5.28M as of Q1 2026.
Citigroup sold 85,723 Elanco Animal Health shares in Q1 2026, an estimated $2.1M.
Elanco Animal Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1929 holding.
Citigroup first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
Citigroup's Elanco Animal Health position peaked at $50.7M in Q1 2019.
515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.